BY
bing yan
Department of Oncology, Hainan Hospital of Chinese People's Liberation Army (PLA) General Hospital
China
- Frontiers in Surgery
- Thoracic Surgery
- Research Topics
- The Emerging Role of Biomarker Mutations in Early Stage Non-small Cell Lung Cancer (NSCLC) Management
The Emerging Role of Biomarker Mutations in Early Stage Non-small Cell Lung Cancer (NSCLC) Management
844
Total downloads
8,361
Total views and downloads
41 Authors
- CZ
chen zhou
Department of Thoracic and Cardiovascular Surgery, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan
China
- DZ
dai zhang
Department of Radiology, The Second Affiliated Hospital of Anhui Medical University
China
- DL
dan li
Department of Oncology, Taihe Hospital, Hubei University of Medicine
China
- HY
hong yao
Cancer Biotherapy Center & Cancer Research Institute, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan
China
- JZ
jie zhao
Department of Thoracic and Cardiovascular Surgery, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan
China
- KS
ke shi
Department of Thoracic Surgery, Beilun District People’s Hospital of Ningbo
China
- LL
li li
Cancer Biotherapy Center & Cancer Research Institute, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan
China
- LY
lianhua ye
The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan
China
- LC
lori c. sakoda
Division of Research, Kaiser Permanente Northern California
United States
- NJ
nathan j. alcasid
Department of Surgery, University of California San Francisco East Bay
United States
- PH
peng han
Department of Radiology, The Second Affiliated Hospital of Anhui Medical University
China
